Background: The association between rosacea and psychiatric comorbidity has been reported previously. However, there is a lack of general population studies about this subject area. Objectives: The aim of this study was to the association between rosacea with depressive and anxiety symptoms at the population level. Methods: A clinical whole-body examination was performed by dermatologists for 1,932 subjects belonging to the Northern Finland Birth Cohort 1966 Study during the 46-year follow-up survey. The presence of depressive and anxiety symptoms was gathered by using validated Hopkins Symptom Checklist-25 (HSCL-25) included in the self-administered questionnaires. Binary logistic regression analysis was used to identify associations between rosacea and psychological symptoms. Results: Rosacea was found in dermatological evaluation in 15.1% of the study subjects (n = 292). In logistic regression analyses, after adjusting for confounding factors, those with rosacea had 1.6-fold (OR 1.55, 95% CI: 1.02–2.32) risk for psychiatric symptoms according to HSCL-25 when compared with controls. In separate analyses of the HSCL-25 depression subscale, the risk was increased, especially for depressive symptoms (OR 1.56, 95% CI: 1.10–2.18). Conclusions: Patients with rosacea seem to have increased risk for depressive and anxiety symptoms in general population. Physicians treating patients with rosacea should pay more attention to the psychosocial health of patients.

1.
Culp B, Scheinfeld N. Rosacea: a review. P T. 2009;34(1):38–45.
2.
Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):S27–35.
3.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study. Dermatology. 2016;232(2):208–13.
4.
Blount BW, Pelletier AL. Rosacea: a common yet commonly overlooked condition. Am Fam Physician. 2002;66(3):435–40.
5.
Oulu U of. University of Oulu: Northern Finland birth cohort 1966.University of Oulu. n.d. http://urn.fi/urn:nbn:fi:att:bc1e5408-980e-4a62-b899-43bec3755243.
6.
Nordström T, Miettunen J, Auvinen J, Ala-Mursula L, Keinänen-Kiukaanniemi S, Veijola J, et al. Cohort profile: 46 years of follow-up of the northern Finland birth cohort 1966 (NFBC1966). Int J Epidemiol. 2022;50(6):1786–7j.
7.
Rantakallio P. Groups at risk in low birth weight infants and perinatal mortality. Acta Paediatr Scand. 1969;193:Suppl 193:1+.
8.
Sinikumpu S-P, Huilaja L, Jokelainen J, Koiranen M, Auvinen J, Hägg PM, et al. High prevalence of skin diseases and need for treatment in a middle-aged population. A northern Finland birth cohort 1966 study. PLoS One. 2014;9(6):e99533.
9.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41; quiz 342–4.
10.
Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46(4):584–7.
11.
Mattisson C, Bogren M, Horstmann V. Correspondence between clinical diagnoses of depressive and anxiety disorders and diagnostic screening via the Hopkins Symptom Check List-25 in the Lundby Study. Nord J Psychiatry. 2013;67(3):204–13.
12.
Veijola J, Jokelainen J, Läksy K, Kantojärvi L, Kokkonen P, Järvelin MR, et al. The Hopkins Symptom Checklist-25 in screening DSM-III-R axis-I disorders. Nord J Psychiatry. 2003;57(2):119–23.
13.
Sandanger I, Moum T, Ingebrigtsen G, Sørensen T, Dalgard OS, Bruusgaard D. The meaning and significance of caseness: the Hopkins symptom checklist-25 and the composite international diagnostic interview II. Soc Psychiatry Psychiatr Epidemiol. 1999;34(1):53–9.
14.
Sandanger I, Moum T, Ingebrigtsen G, Dalgard OS, Sørensen T, Bruusgaard D. Concordance between symptom screening and diagnostic procedure: the Hopkins symptom checklist-25 and the composite international diagnostic interview I. Soc Psychiatry Psychiatr Epidemiol. 1998;33(7):345–54.
15.
Fluharty M, Taylor AE, Grabski M, Munafò MR. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res. 2017;19(1):3–13.
16.
Davidson KM. Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry. 1995;166(2):199–204.
17.
Rebar AL, Stanton R, Geard D, Short C, Duncan MJ, Vandelanotte C. A meta-meta-analysis of the effect of physical activity on depression and anxiety in non-clinical adult populations. Health Psychol Rev. 2015;9(3):366–78.
18.
Opel N, Redlich R, Grotegerd D, Dohm K, Heindel W, Kugel H, et al. Obesity and major depression: body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations. Psychoneuroendocrinology. 2015;51:219–26.
19.
Domènech-Abella J, Mundó J, Leonardi M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, et al. The association between socioeconomic status and depression among older adults in Finland, Poland and Spain: a comparative cross-sectional study of distinct measures and pathways. J Affect Disord. 2018;241:311–8.
20.
Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82(6):816–20.
21.
Dai R, Lin B, Zhang X, Lou Y, Xu S. Depression and anxiety in rosacea patients: a systematic review and meta-analysis. Dermatol Ther. 2021;11(6):2089–105.
22.
Chang HC, Huang YC, Lien YJ, Chang YS. Association of rosacea with depression and anxiety: A systematic review and meta-analysis. J Affect Disord. 2022;299:239–45.
23.
Cardwell LA, Farhangian ME, Alinia H, Kuo S, Feldman SR. Psychological disorders associated with rosacea: analysis of unscripted comments. J Dermatol Dermatol Surg. 2015;19(2):99–103.
24.
Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014;71(5):973–80.
25.
Mindell JS, Giampaoli S, Goesswald A, Kamtsiuris P, Mann C, Männistö S, et al. Sample selection, recruitment and participation rates in health examination surveys in Europe: experience from seven national surveys. BMC Med Res Methodol. 2015;15:78–8.
You do not currently have access to this content.